Visual impairment and mortality in patients with type 2 diabetesBMJ OPEN DIABETES RESEARCH & CAREIF4.12019-10-1113OAAI
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidatesMOLECULAR METABOLISMIF6.62018-02-01112OAAI
Bone morphogenetic protein 4 inhibits insulin secretion from rodent beta cells through regulation of calbindin1 expression and reduced voltage-dependent calcium currentsDIABETOLOGIAIF10.22015-04-0219OAAI
Inhibition of beta cell growth and function by bone morphogenetic proteinsDIABETOLOGIAIF10.22014-09-2734OAAI
Motivation, effort and life circumstances as predictors of foot ulcers and amputations in people with Type 2 diabetes mellitusDIABETIC MEDICINEIF3.42014-08-089PREAI
Amputations and foot ulcers in patients newly diagnosed with Type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidityDIABETIC MEDICINEIF3.42013-04-2684PREAI
Partial promoter substitutions generating transcriptional sentinels of diverse signaling pathways in embryonic stem cells and miceDISEASE MODELS & MECHANISMSIF3.32012-01-0117OAAI
Suppressor of cytokine signalling-3 inhibits tumor necrosis factor-alpha induced apoptosis and signalling in beta cellsMOLECULAR AND CELLULAR ENDOCRINOLOGYIF3.62009-11-0131OAAI
IL-1β-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cellsDIABETOLOGIAIF10.22008-11-1122OAAI
Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejectionDIABETOLOGIAIF10.22008-07-2231OAAI